Orange Book Search (FDA) - DRUGDATAEXPY

Current Location： Home > Orange Book Search (FDA) Feedback Help

Application No

RLD

Proprietary Name

Exact

Approval Date

-

Active Ingredient

Exact

Patent(Yes/No)

Company

Patent Expiration

-

Dosage Form;Route

Substance Patent Expiration

-

Strength

Product Patent Expiration

-

Application Type

Exclusivity Expiration

-

Marketing Status

Patent No

Export data

Application No	Product No	Proprietary Name	Active Ingredient	Dosage Form;Route	Strength	Company	Approval Date	RLD	Marketing Status	TE Code
(NDA) 020978	001	ZIAGEN	ABACAVIR SULFATE	SOLUTION;ORAL	EQ 20MG BASE/ML	VIIV HLTHCARE	1998-12-17	Yes	RX	AA
(NDA) 020977	001	ZIAGEN	ABACAVIR SULFATE	TABLET;ORAL	EQ 300MG BASE	VIIV HLTHCARE	1998-12-17	Yes	DISCN
(ANDA) 091294	001	ABACAVIR SULFATE	ABACAVIR SULFATE	TABLET;ORAL	EQ 300MG BASE	MYLAN PHARMS INC	2012-06-18	No	RX	AB
(ANDA) 201107	001	ABACAVIR SULFATE	ABACAVIR SULFATE	SOLUTION;ORAL	EQ 20MG BASE/ML	HETERO LABS LTD III	2016-09-26	No	RX	AA
(ANDA) 091560	001	ABACAVIR SULFATE	ABACAVIR SULFATE	TABLET;ORAL	EQ 300MG BASE	HETERO LABS LTD III	2013-09-13	No	RX	AB
(ANDA) 077844	001	ABACAVIR SULFATE	ABACAVIR SULFATE	TABLET;ORAL	EQ 300MG BASE	AUROBINDO PHARMA LTD	2012-12-17	No	RX	AB
(ANDA) 078119	001	ABACAVIR SULFATE	ABACAVIR SULFATE	TABLET;ORAL	EQ 300MG BASE	CIPLA	2017-11-21	No	RX	AB
(ANDA) 091050	001	ABACAVIR SULFATE	ABACAVIR SULFATE	TABLET;ORAL	EQ 300MG BASE	STRIDES PHARMA	2016-10-28	No	RX	AB
(ANDA) 077950	001	ABACAVIR SULFATE	ABACAVIR SULFATE	SOLUTION;ORAL	EQ 20MG BASE/ML	AUROBINDO PHARMA LTD	2018-03-14	No	RX	AA
(ANDA) 201570	001	ABACAVIR SULFATE	ABACAVIR SULFATE	TABLET;ORAL	EQ 300MG BASE	APOTEX INC	2012-12-17	No	DISCN
(NDA) 205551	001	TRIUMEQP	ABACAVIR SULFATE; DOLUTEGRAVIR SODIUM; LAMIVUDINE	TABLET;ORAL	EQ 600MG BASE;EQ 50MG BASE;300MG	VIIV HLTHCARE	2014-08-22	Yes	RX
(NDA) 215413	001	TRIUMEQ PDP	ABACAVIR SULFATE; DOLUTEGRAVIR SODIUM; LAMIVUDINE	TABLET, FOR SUSPENSION;ORAL	EQ 60MG BASE;EQ 5MG BASE;30MG	VIIV HLTHCARE	2022-03-30	Yes	RX
(ANDA) 208990	001	ABACAVIR SULFATE AND LAMIVUDINE	ABACAVIR SULFATE; LAMIVUDINE	TABLET;ORAL	EQ 600MG BASE;300MG	ZYDUS PHARMS	2018-11-15	No	DISCN
(ANDA) 206151	001	ABACAVIR SULFATE AND LAMIVUDINE	ABACAVIR SULFATE; LAMIVUDINE	TABLET;ORAL	EQ 600MG BASE;300MG	AUROBINDO PHARMA	2017-03-28	No	DISCN
(ANDA) 091144	001	ABACAVIR SULFATE AND LAMIVUDINE	ABACAVIR SULFATE; LAMIVUDINE	TABLET;ORAL	EQ 600MG BASE;300MG	CIPLA	2017-03-28	No	RX	AB
(ANDA) 079246	001	ABACAVIR SULFATE AND LAMIVUDINE	ABACAVIR SULFATE; LAMIVUDINE	TABLET;ORAL	EQ 600MG BASE;300MG	TEVA PHARMS USA	2016-09-29	No	DISCN
(ANDA) 090159	001	ABACAVIR SULFATE AND LAMIVUDINE	ABACAVIR SULFATE; LAMIVUDINE	TABLET;ORAL	EQ 600MG BASE;300MG	AUROBINDO PHARMA LTD	2018-11-15	No	RX	AB
(ANDA) 216332	001	ABACAVIR SULFATE AND LAMIVUDINE	ABACAVIR SULFATE; LAMIVUDINE	TABLET;ORAL	EQ 600MG BASE;300MG	LAURUS	2022-07-25	No	RX	AB
(NDA) 204311	001	ABACAVIR SULFATE AND LAMIVUDINE	ABACAVIR SULFATE; LAMIVUDINE	TABLET, FOR SUSPENSION;ORAL	EQ 60MG BASE;30MG	MYLAN LABS LTD	2023-12-22	Yes	DISCN
(ANDA) 204990	001	ABACAVIR SULFATE AND LAMIVUDINE	ABACAVIR SULFATE; LAMIVUDINE	TABLET;ORAL	EQ 600MG BASE;300MG	CHARTWELL RX	2017-03-28	No	RX	AB